Development of Objective Measures for Use in Pediatric Drug Trials for Psychiatric and Neurodevelopmental Disorders
This effort aims to stimulate research in a major gap area in pediatric psychopharmacology for psychiatric and neurodevelopmental disorders, by encouraging the development of objective pediatric central nervous system (CNS) measures that can be incorporated into pharmacologic trials.
Related Posts
Development of Objective Measures for Use in Pediatric Drug Trials for Psychiatric and Neurodevelopmental Disorders
November 21, 2025
This effort aims to stimulate research in a major gap area in pediatric...
Mentoring Networks for Mental Health Research Education
November 21, 2025
This is a re-issue of a long-standing R25 program announcement that aims to...
Short Courses for Mental Health Research Education
November 21, 2025
This is a re-issue of a long-standing R25 program announcement that aims to...
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research Concept Clearance: August 27, 2025 Presenter: Suzanne
November 21, 2025
The purpose of the Conte Centers program is to support interdisciplinary teams of...